Search
for
Sort by
Research 331–360 of 1000+
- Androgen Secreting Steroid Cell Tumor of the Ovary Represented with Postmenopasal Bleeding and Extensive Hirsutism
- Supplements That May Counteract Side Effects from Conventional Cancer Therapies
- Queries and Minor Notes
- Bladder Cancer Survival of Men Receiving 5α-Reductase Inhibitors
- Cutaneous manifestations of metabolic diseases: uncommon presentations
- Use of natural molecules as anti-angiogenic inhibitors for vascular endothelial growth factor receptor
- Bladder cancer survival in men using 5-alpha-reductase inhibitors
- Nature-skin-based multi-responsive controlled-release electroactive scaffolds for integrated melanoma postoperative relapse prevention and wound therapy
- Cost of prevalent psoriasis
- Dermatologic applications of direct-to-consumer genomic analysis
- Changing incidence trends of cutaneous B-cell lymphoma
- Mesenchymal Stem Cell Secretome: Toward Cell-Free Therapeutic Strategies in Regenerative Medicine
- Aging and Immortality: Quasi-Programmed Senescence and Its Pharmacologic Inhibition
- Mucocutaneous reactions to chemotherapy
- Pathobiology of chemotherapy-induced hair loss
- Dermatoses of pregnancy
- The PDGF/PDGFR pathway as a drug target
- Cutaneous complications of chemotherapeutic agents
- Hair and cancer chemotherapy: consequences and nursing care - a literature study
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer
- TGF-β family signaling in stem cells
- A randomized trial of minoxidil in chemotherapy-induced alopecia
- Cutaneous reactions to recombinant cytokine therapy
- Docetaxel, cisplatin and 5-fluorouracil in patients with locally advanced unresectable head and neck cancer: a phase I–II feasibility study
- Physiological and biological skin changes in pregnancy
- Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- Fulvestrant, a new treatment option for advanced breast cancer: tolerability versus existing agents
- Androgen receptors and their biology
- Alisertib is active as single agent in recurrent atypical teratoid rhabdoid tumors in 4 children